Shirley Ryan AbilityLab   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Chicago IL United States (1954)

Organization Overview

First Clinical Trial
2010
NCT01510457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Dr. Norman Harden | Shirley Ryan AbilityLab | Shirley Ryan Ability Lab | Shirley Ryan AbilityLab and University of Illinois at Chicago (UIC)